HomeIMMX • NASDAQ
add
Immix Biopharma Inc
Previous close
$2.34
Day range
$2.35 - $2.62
Year range
$1.26 - $2.71
Market cap
72.48M USD
Avg Volume
265.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.68M | -16.23% |
Net income | -4.54M | 13.62% |
Net profit margin | — | — |
Earnings per share | -0.15 | 31.82% |
EBITDA | -4.64M | 16.87% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.92M | -45.70% |
Total assets | 19.89M | -42.09% |
Total liabilities | 10.30M | 53.35% |
Total equity | 9.59M | — |
Shares outstanding | 27.88M | — |
Price to book | 6.88 | — |
Return on assets | -54.66% | — |
Return on capital | -93.74% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.54M | 13.62% |
Cash from operations | -1.69M | 55.97% |
Cash from investing | -67.71K | 77.57% |
Cash from financing | — | — |
Net change in cash | -1.76M | -114.91% |
Free cash flow | 208.38K | 107.89% |
About
Founded
2012
Headquarters
Website
Employees
18
